Option chain shows key data for Clever Leaves Holdings's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Clever Leaves Holdings.

Clever Leaves Holdings (OTC:CLVRW) Stock, Option Chain

Clever Leaves Holdings Inc is a producer of pharmaceutical and consumer cannabis brands. The company operates and has investments in Canada, Colombia, Germany, Portugal, and the United States. The company operates in two reportable segments namely, the Cannabinoid segment which is comprised of the company's cultivation, extraction, and commercialization of cannabinoid products; and the Non-Cannabinoid operating segment which generates maximum revenue and is engaged in the business of formulating, manufacturing, marketing, selling, distributing, and otherwise commercializing nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements.

Photo by Jhon David on Unsplash

Cannabis

Earnings

News

Penny Stocks

Retail Sales

Markets

CLVR

CLVRW

Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) reported its financial results late Monday for the fourth quarter and full year concluded on December 31, 2023. 

Cannabis Company Clever Leaves Reports Q4 And 2023 Results: Revenue Growth And Expense Reductions

Europe Euro rain Cannabis (M.KOS and MVelishchuk on Shutterstock)(5)

Regulations

AKAN

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

FLWPF

TLRY

TSX:TLRY

TSXV:FLWR

The European cannabis market is one of the most rapidly expanding markets globally.Prohibition Partners revealed in its latest report on cannabis in Europe that the combined market size of all CBD categories surpassed €2 billion ($2.2 billion) in 2023. Moreover, the report called Germany, Czech Republic, Switzerland and the Netherlands &#34;early adopters&#34; that are working on developing regulatory models for the recreational cannabis market, and are &#34;likely to set a precedent for other countries to follow.&#34; Germany&#39;s recent partial legalization of cannabis has shaken up the industry and moved marijuana stocks, leaving everyone wondering about a domino effect on other European countries. On Thursday, Tilray - which debuted in Portugal in 2021 - announced another achievement in the new burgeoning market. Following the approval of its whole flower THC 18, Tilray&#39;s subsidiary Tilray Medical, received the green light for the first medical cannabis extract, Tilray Oral Solution THC 5 CBD 20, in Portugal. In the meantime, Curaleaf International, part of Curaleaf Holdings Inc. - which has already established its presence in the European market - announced its expansion in the Czech Republic, via a new supply agreement with Astrasana Pharma s.r.o.

Weed Giants Tilray And Curaleaf Ramp Up Presence In Europe, Here&#39;s Why

AI generated image

Biotech

Health Care

General

AVCNF

KHIRON LIFE SCIENCES CORP by Khiron Life Sciences Corp.

KHRNF

PCLOF

TSX:AVCN

Can Cannabis Treat Severe Forms Of Epilepsy? New Medicine Sparks Hope As Colombia&#39;s Weed Industry Goes Global

Comments

Clever Leaves Holdings

Clever Leaves Holdings (CLVRW) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga